Microbial-derived tryptophan catabolites, kidney disease and gut inflammation

HIGHLIGHTS

  • who: Avra Melina Madella et al. from the Department of Pharmaceutical Sciences, Utrecht University, Universiteitsweg, CG Utrecht, The Netherlands have published the research work: Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation, in the Journal: Toxins 2022, 14, x FOR PEER REVIEW of /2022/
  • what: The aim of this review is to examine uremic metabolites that have been synthesised by bacteria from dietary sources.
  • how: This review discusses the origins of these catabolites their effect on organ systems and how these can be manipulated therapeutically in the future as a strategy to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?